A clinical trial for semaglutide, the active ingredient in Ozempic, found that it improved blood sugar control in people with ...

Amanda Smith has kicked insulin to the curb in what experts are calling a milestone in the fight against Type 1 diabetes.

In a small cell therapy trial, 10 out of 12 people with type 1 diabetes no longer needed supplemental insulin, even a year after treatment.

"The medication's going to be 50 percent of your journey, and the other 50 percent is still what you choose to eat and the ...

Swiss company PharmaSens and SiBionics have entered a development partnership for niia signature, an all-in-one wearable that ...

Most in a small group of patients receiving a stem cell-based infusion no longer needed insulin, but the drug may not suit ...

Tsimikas, vice president of San Diego’s Scripps Whittier Diabetes Institute, helped deliver positive news for the estimated 7 million Americans who take insulin every day to manage their type 2 ...

The chief product and customer experience officer said Insulet has seen an uptick in users with Type 2 diabetes since ...

Dr. Lily Ackermann discussed inpatient diabetes care, focusing on real-world decisions and personalized treatment using ...

New study results demonstrated the safety and efficacy of the MannKind Afrezza inhaled insulin offering for children with ...

A novel weight loss drug in the same class as semaglutide has successfully met its targets in its largest clinical trial yet, ...